Formulazioni di risankizumab ad alta concentrazione

Swiss patent · CH722597 · In force

Register entry

Publication number
CH722597
Application number
CH000865/2026
Kind
Swiss patent
Status
In force
Specification
Application, without search report
Filed
Dec 19, 2024
Published
Aug 1, 2026
Protection ends at the latest
Dec 18, 2044
Next annual fee due
Dec 31, 2027
IPC classes
A61K 39/395 (2006.01)
Priority
US 63/612,905 20.12.2023
US 63/612,928 20.12.2023
PCT application
PCT/US2024/061124 19.12.2024
PCT publication
WO2025/137347 26.06.2025
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Specification status

    Specification status
    Non-published patent application → Patent application without search report
    Publication date
    01.08.2026

    Published in Swissreg on 01.08.2026

Parties

Inventor

Chen Wang

North Chicago, IL 60064, US

Georgeen Gaza-Bulseco

North Chicago, IL 60064, US

Johanna Lindermuth Gervais

North Chicago, IL 60064, US

Jie Wang

North Chicago, IL 60064, US

Eva-Maria Knoch

67061 Ludwigshafen, DE

Isabelle Deimel

67061 Ludwigshafen, DE

Katharina Kaleta

67061 Ludwigshafen, DE

Michael Siedler

67061 Ludwigshafen, DE

Xue Mi

North Chicago, IL 60064, US

Lihua Yang

North Chicago, IL 60064, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.